Delivery Order SPE2DB20D2104-SPE2DB24FT90U
- Not listed
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 8 mg Ondansetron hydrochloride tablets, used to treat nausea and vomiting, with a ceiling value of $5,665.56 and a completion date of January 20, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,753.70 and a completion date of February 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen also holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,586.96 and a completion date of January 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,050.14 and is a firm fixed-price, delivery order contract with a completion date of March 18, 2025. This contract is not set aside for any specific business type....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a total ceiling value of $11,126.30 and an ultimate completion date of December 30, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,338.60 firm fixed-price contract is for the delivery of ondansetron hydrochloride 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which Amerisourcebergen holds with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,652.19 and a period of performance that runs through May 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT90UDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,713.47 and a period of performance through April 30, 2024. The contract is for the procurement of ondansetron hydrochloride 4 mg tablets, a medication used to prevent nausea and vomiting. This contract is not associated with a set-aside program. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/29/24 |